Cas no 1806303-32-1 (3,4-Dichloro-5-iodopyridine)
3,4-Dichloro-5-iodopyridine Chemical and Physical Properties
Names and Identifiers
-
- 3,4-dichloro-5-iodopyridine
- 3,4-Dichloro-5-iodopyridine
-
- Inchi: 1S/C5H2Cl2IN/c6-3-1-9-2-4(8)5(3)7/h1-2H
- InChI Key: LXUDDHJPVDDYFK-UHFFFAOYSA-N
- SMILES: IC1C=NC=C(C=1Cl)Cl
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 101
- XLogP3: 2.8
- Topological Polar Surface Area: 12.9
3,4-Dichloro-5-iodopyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A029007441-250mg |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 250mg |
$989.80 | 2022-03-31 | |
| Alichem | A029007441-500mg |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 500mg |
$1,685.00 | 2022-03-31 | |
| Alichem | A029007441-1g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 1g |
$2,779.20 | 2022-03-31 | |
| Aaron | AR01K0HK-1g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 1g |
$276.00 | 2025-07-04 | |
| Aaron | AR01K0HK-5g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 5g |
$827.00 | 2025-07-04 | |
| eNovation Chemicals LLC | Y1405815-1g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 95% | 1g |
$1275 | 2025-07-04 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 2338881-100g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | ≥95% | 100g |
¥34995.00 | 2025-07-04 | |
| A2B Chem LLC | BA12268-250mg |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 97% | 250mg |
$97.00 | 2025-07-04 | |
| A2B Chem LLC | BA12268-500mg |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 97% | 500mg |
$121.00 | 2025-07-04 | |
| A2B Chem LLC | BA12268-1g |
3,4-Dichloro-5-iodopyridine |
1806303-32-1 | 97% | 1g |
$153.00 | 2025-07-04 |
3,4-Dichloro-5-iodopyridine Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on 3,4-Dichloro-5-iodopyridine
Professional Introduction to 3,4-Dichloro-5-iodopyridine (CAS No. 1806303-32-1)
3,4-Dichloro-5-iodopyridine, with the chemical formula C?H?Cl?IN, is a significant intermediate in modern pharmaceutical and agrochemical synthesis. This compound, identified by its CAS number 1806303-32-1, has garnered considerable attention due to its versatile reactivity and utility in constructing complex molecular architectures. Its unique structural features—comprising a pyridine core substituted with chlorine and iodine atoms—make it a valuable building block for various synthetic applications.
The compound’s significance in synthetic chemistry stems from its ability to participate in multiple reaction pathways, including cross-coupling reactions, nucleophilic substitutions, and metal-catalyzed transformations. These properties have positioned 3,4-Dichloro-5-iodopyridine as a cornerstone in the development of novel heterocyclic compounds, which are increasingly prevalent in medicinal chemistry.
Recent advancements in the field of organometallic chemistry have highlighted the compound’s role in palladium-catalyzed cross-coupling reactions. For instance, studies have demonstrated its efficacy in Suzuki-Miyaura and Stille couplings, enabling the efficient construction of biaryl systems and polyhalogenated pyridines. These transformations are particularly relevant in drug discovery, where biaryl motifs are frequently encountered in active pharmaceutical ingredients (APIs). The ability to introduce iodine at the 5-position of the pyridine ring further enhances its utility, as iodine can serve as a handle for subsequent functionalization via palladium-mediated reactions.
In addition to its applications in cross-coupling chemistry, 3,4-Dichloro-5-iodopyridine has been explored as a precursor in the synthesis of pharmacologically active compounds. Researchers have leveraged its reactivity to develop novel kinase inhibitors and antiviral agents. For example, recent studies have reported the use of this compound in generating substituted pyridines that exhibit inhibitory activity against specific targets implicated in cancer and infectious diseases. The chlorine substituents at the 3 and 4 positions provide additional sites for selective modification, allowing chemists to fine-tune the pharmacokinetic and pharmacodynamic properties of derived molecules.
The agrochemical sector has also benefited from the versatility of 3,4-Dichloro-5-iodopyridine. Its incorporation into synthetic pathways has led to the development of new herbicides and fungicides with improved efficacy and environmental profiles. By serving as a key intermediate, this compound enables the creation of structurally diverse agrochemicals that target specific enzymatic pathways in pests and pathogens while minimizing toxicity to non-target organisms.
From a computational chemistry perspective, 3,4-Dichloro-5-iodopyridine has been subjected to detailed quantum mechanical calculations to elucidate its reactivity mechanisms. These studies have provided insights into how electronic effects influence its participation in various organic transformations. Such computational insights are crucial for guiding experimental design and optimizing reaction conditions, thereby enhancing yield and selectivity in synthetic protocols.
The industrial production of 3,4-Dichloro-5-iodopyridine (CAS No. 1806303-32-1) typically involves multi-step synthetic routes that prioritize scalability and cost-efficiency. Manufacturers often employ halogenation strategies starting from commercially available pyridine derivatives. Advances in green chemistry have also prompted investigations into more sustainable methods for synthesizing this compound, including catalytic processes that reduce waste generation and energy consumption.
The compound’s stability under various storage conditions is another critical consideration for industrial applications. Research has focused on optimizing packaging materials and storage protocols to ensure long-term viability while maintaining chemical purity. This is particularly important for pharmaceutical intermediates, where degradation products can impact downstream processing and final product quality.
Future research directions for 3,4-Dichloro-5-iodopyridine may explore its potential in photoredox catalysis and electrochemical organic synthesis. The presence of both halogen atoms makes it an attractive candidate for light-driven reactions or electrochemical functionalization strategies, which could offer greener alternatives to traditional thermal methods.
In summary,3,4-Dichloro-5-iodopyridine (CAS No. 1806303-32-1) remains a pivotal compound in synthetic chemistry due to its broad utility across multiple disciplines. Its role as an intermediate in pharmaceuticals, agrochemicals, and advanced materials underscores its importance in modern chemical research and industrial applications. As methodologies continue to evolve toward greater efficiency and sustainability,3,4-Dichloro-5-iodopyridine will undoubtedly continue to play a central role in shaping the future of molecular synthesis.
1806303-32-1 (3,4-Dichloro-5-iodopyridine) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)